Last Updated: 10/03/19
Preclinical Development Stage NExT Projects
| Applicant | Institute | Project |
|---|---|---|
| Brown, Bob | Dicerna Pharmaceuticals, Inc. | β-catenin/CTNNB1 DsiRNA LNP Therapeutic for HCC and CRC |
| Markowitz, Sanford | Case Western Reserve University | SW033291 Markedly Accelerates Tri-Lineage Recovery After Marrow Transplant |
| Perera, Liyanage | National Cancer Institute, Center for Cancer Research, NIH | CARs targeting the chemokine receptor CCR4 as a therapeutic modality for T-cell leukemias |
| Rittenhouse-Olson, Kate | For-Robin, Inc | hJAA-F11, a Humanized Anti-Thomsen Friedenreich Antibody for Cancer Therapy |
| Schnitzer, Jan | Proteogenomics Research Institute for Systems Medicine | Developing hAnnA1-based immunoconjugates for cancer detection and treatment |